Hosoya, Tatsuo
Fushimi, Masahiko
Okui, Daisuke
Sasaki, Tomomitsu
Ohashi, Tetsuo
Article History
Received: 2 October 2019
Accepted: 5 December 2019
First Online: 26 December 2019
Compliance with ethical standards
:
: Fuji Yakuhin Co., Ltd. (Fuji), the manufacturer of dotinurad, sponsored this study. TH was advisor to Fuji regarding this study and received consultant and manuscript fees. The other authors were employees of Fuji.
: The study protocol and informed consent document were reviewed and approved by an institutional review board (Shinagawa East One Medical Clinic, Tokyo, Japan; Tokyo University Hospital, Tokyo, Japan; Kyoto University Hospital, Kyoto, Japan). Informed consent was obtained from all individual participants included in the study. The tests were conducted in compliance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards, Good Clinical Practice guidelines, and other regulatory requirements that were relevant. The information in this study was registered with Clinical Trials.gov (ClinicalTrials.gov number: NCT03006445).